Related Experiment Videos
Treatment of hyperthyroidism with potassium iodide
G Philippou1, G Piperingos, A Souvatzoglou
1Athens University, Department of Clinical Therapeutics, Alexandra General Hospital, Greece.
Experimental and Clinical Endocrinology
|May 1, 1991
Summary
Potassium iodide effectively lowered thyroid hormones (T3 and T4) in Basedow's disease patients within weeks. However, normal individuals showed minimal hormone changes and increased thyroid-stimulating hormone (TSH).
Area of Science:
- Endocrinology
- Thyroid disorders
- Pharmacology
Background:
- Basedow's disease (Graves' disease) is an autoimmune disorder causing hyperthyroidism.
- Thyroid hormone levels (T3, T4) are critical indicators of thyroid function.
- Thyroid-stimulating hormone (TSH) plays a key role in regulating thyroid hormone production.
Purpose of the Study:
- To investigate the effects of potassium iodide on thyroid hormone levels in patients with Basedow's disease.
- To compare the impact of potassium iodide on thyroid function in hyperthyroid patients versus normal controls.
Main Methods:
- A 5-week study involving 17 patients with Basedow's disease and 12 normal controls.
- Administration of potassium iodide to all participants.
- Monitoring of serum T3, T4, and TSH levels throughout the study period.
Main Results:
- Thyrotoxic patients showed a significant decrease in serum T3 and T4 levels, with maximum reduction at 2 and 3 weeks, respectively.
- Some hyperthyroid patients maintained normal hormone levels even after 5 weeks of treatment.
- Euthyroid individuals exhibited a slight decrease in T4 and T3, accompanied by an increase in serum TSH.
Conclusions:
- Potassium iodide demonstrates efficacy in reducing thyroid hormone levels in hyperthyroid patients.
- The response to potassium iodide can vary among individuals with Basedow's disease.
- Potassium iodide influences thyroid hormone regulation and TSH levels in euthyroid individuals.